Alkermes plc (8AK) - Total Liabilities

Latest as of December 2025: €667.70 Million EUR ≈ $780.61 Million USD

Based on the latest financial reports, Alkermes plc (8AK) has total liabilities worth €667.70 Million EUR (≈ $780.61 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 8AK cash flow metrics to assess how effectively this company generates cash.

Alkermes plc - Total Liabilities Trend (2013–2025)

This chart illustrates how Alkermes plc's total liabilities have evolved over time, based on quarterly financial data. Check Alkermes plc (8AK) asset resilience to evaluate the company's liquid asset resilience ratio.

Alkermes plc Competitors by Total Liabilities

The table below lists competitors of Alkermes plc ranked by their total liabilities.

Company	Country	Total Liabilities
Liberty Broadband Srs C NASDAQ:LBRDK	USA	$3.13 Billion
Jiangsu King's Luck Brewery Joint-Stock Co Ltd SHG:603369	China	CN¥7.97 Billion
Taiwan Business Bank TW:2834	Taiwan	NT$2.32 Trillion
Alfa S.A.B. de C.V. MX:ALFAA	Mexico	MX$107.90 Billion
Andon Health Co Ltd SHE:002432	China	CN¥6.56 Billion
Caris Life Sciences, Inc. Common Stock NASDAQ:CAI	USA	$548.36 Million
Victory Capital Holdings Inc NASDAQ:VCTR	USA	$1.82 Billion
Chartwell Retirement Residences TO:CSH-UN	Canada	CA$3.35 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Alkermes plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Alkermes plc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alkermes plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alkermes plc (2013–2025)

The table below shows the annual total liabilities of Alkermes plc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€667.70 Million ≈ $780.61 Million	+13.06%
2024-12-31	€590.59 Million ≈ $690.46 Million	-36.74%
2023-12-31	€933.54 Million ≈ $1.09 Billion	+1.45%
2022-12-31	€920.23 Million ≈ $1.08 Billion	+0.91%
2021-12-31	€911.90 Million ≈ $1.07 Billion	+39.49%
2018-12-31	€653.72 Million ≈ $764.27 Million	+9.98%
2017-12-31	€594.42 Million ≈ $694.94 Million	+14.99%
2016-12-31	€516.94 Million ≈ $604.36 Million	-4.53%
2015-12-31	€541.47 Million ≈ $633.03 Million	+3.69%
2014-12-31	€522.22 Million ≈ $610.53 Million	+1.92%
2013-12-31	€512.40 Million ≈ $599.05 Million	--

About Alkermes plc

F:8AK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$5.50 Billion

€4.71 Billion EUR

Market Cap Rank

#3593 Global

#658 in Germany

Share Price

€28.32

Change (1 day)

-1.77%

52-Week Range

€23.40 - €30.20

All Time High

€30.20